
Division Chief Surgical Oncology and Endocrine Surgery @MayoAZSurg| Associate Chair Education| Certified Physician Executive| Health Services Researcher
Joined April 2026
- Tweets52
- Following101
- Followers122
- Likes10
Pinned Tweet
Looking forward to sharing ideas and thoughts on the future of cancer care, academic medicine, and surgical leadership.
1
971
Nabil Wasif MD, MPH, CPE retweeted
Matthew R. Callstrom, M.D., Ph.D., has been elected by the Mayo Clinic Board of Trustees to succeed Gianrico Farrugia, M.D., as president and CEO, effective Jan. 1, 2027.
Read the full announcement: mayocl.in/4zMJdVZ
There is a disconnect between how research is funded vs. what cancers are most lethal.
The graphic below shows National Cancer Institute funding for cancer research for 2026 compared with the leading sites of estimated deaths due to cancer. Lung, colorectal, and pancreatic cancer are the number 1-3 leading causes of cancer deaths (combined), yet receive 8.3% of R01 grants.
Make it make sense!
4
249
There's the circle of life and then there's the circle of academic life!
Delighted to welcome Dr. Patty Lu back to Mayo Clinic Arizona after completing her Endocrine Surgery Fellowship at the University of Chicago.
Patty is a superstar graduate of our surgical residency and a recipient of the Mayo Brothers Distinguished Fellowship Award, the highest honor a trainee can achieve in the Mayo Clinic system. Along the way, she earned a Masters in Healthcare Innovation and built an impressive academic track record.
I still remember interviewing Dr. Lu as Program Director and it's incredibly rewarding to have her return as a colleague!
@MayoAZSurg @Chee_CheeStucky @ZhiVenFongMD @AJMeltzerMD @mdpattylu
Nabil Wasif MD, MPH, CPE retweeted
Pancreatic cancer is one of the deadliest forms of cancer, in part because it often is diagnosed at an advanced stage. For some patients, treatment may include a complex surgery known as the Whipple procedure.
Dr. Zhi Ven Fong, a Mayo Clinic surgical oncologist and hepatobiliary and pancreas surgeon, explains the procedure: mayocl.in/4ieXsMU
Kudos to the SSO for a long overdue re-think on Surgical Oncology Fellowship training.
There is absolutely a place for surgeon-scientists but training pathways should not be built around them. Clinical demand for cancer surgery is only going to grow with an aging population.
October Issue: Reimagining the Training Paradigm in #ComplexGeneralSurgicalOncology : Aligning Selection, Training, and Workforce Reality @bermar01
ow.ly/N1yr50ZZ3PM
@SyedAAhmad5
@SocSurgOnc
6
378
Nabil Wasif MD, MPH, CPE retweeted
October Issue: Reimagining the Training Paradigm in #ComplexGeneralSurgicalOncology : Aligning Selection, Training, and Workforce Reality @bermar01
ow.ly/N1yr50ZZ3PM
@SyedAAhmad5
@SocSurgOnc
Arguably the first seismic shift in any field directly attributable to AI.
What would be the equivalent in the field of medicine? The Millennium Prize Problems that have frustrated generations of physicians?
My vote is identifying the underlying cause of the most common human diseases- hypertension, diabetes, Alzheimer’s, CAD and a host of auto-immune disorders. All of these we ‘treat’ but not really cure.
What Are the Remaining Millennium Prize Problems? nytimes.com/2026/10/08/scien… via @NYTimes
2
82
Timely article on data generated by wearables! I am conducting my own prospective study comparing my Garmin, Whoop and Oura to how I subjectively feel after working out and first thing in the morning. So far the correlation is good but not great 🤔
Over 100 million Americans use wearable sensors, including smartwatches, rings, and wrist bands. They provide data for HRV and Readiness scores. What is the story with these metrics?
1
2
218
Interested in joining a top-ranked cancer center and helping define the future of cancer discovery?
The Mayo Clinic Comprehensive Cancer Center (MCCCC) has launched a national recruitment initiative for scientific research faculty and clinician investigator positions.
👇
jobs.mayoclinic.org/scientis…
Fantastic course for surgeon leaders at the Kellogg Global Hub, Northwestern School of Management.
Executive presence, Artificial Intelligence, financial statements, change management, values based culture and so much more.
Thanks to the SUS, admin staff and of course the all-star teaching team!
Merch wasn’t bad either😉
@UnivSurg
@KelloggSchool
1
7
536
Nabil Wasif MD, MPH, CPE retweeted
Welcome to our new Plastic Surgery consultants, Drs Max Shrout, Christine Oh, and Annie Wang!
Dr Shrout completed fellowship in Peds PRS at U of Texas. Dr Oh completed fellowship in hand & microsurgery at Mayo Clinic. Dr Wang completed microvascular recon fellowship at MDACC.
🎉
Why would any graduating General Surgery resident go into Bariatric surgery now? The drugs are only going to get better….
Amid rapid GLP-1 receptor agonist adoption, bariatric surgery volume declined 49% from 2021 to 2025, while bariatric surgeons maintained operative activity by shifting toward other general surgery procedures. ovid.com/10.1097/SLA.0000000…
3
230
Epic and OpenAI- a marriage made in heaven?!
The integration of ChatGPT for Healthcare into Epic is the first baby step into what is likely going to be transformative for the EHR. As any physician will tell you, the EHR is like democracy. Not perfect but the best we have.
Can AI finally fulfill the promise of the electronic health record? Strip away the mindless alerts, end the click fests, and unearth those hidden menus?
One can only hope, but this seems like a step in the right direction.
openai.com/index/chatgpt-con…
1
73
1 in a million!
That is what I estimate is the chance that 4 medical professionals of Pakistani origin working together as part of a multi-disciplinary surgical team.
And yesterday it happened! Myself, Nisha Rehman (General Surgery resident), Mouneeb Choudry (Urology resident) and Shiza Atif (rotating medical student) were all present for an epic case.
Different generations with a shared heritage and a single purpose!
Nabil Wasif MD, MPH, CPE retweeted
The @FDA approved the drug daraxonrasib for advanced pancreatic cancer. It's the first to extend patients' lives. Our researchers, Drs. Mitesh Borah, an investigator on the drug trial, and Tanios Bekaii-Saab @GIcancerDoc, both leaders in novel therapeutics, share the impact.


























